A blood test for detection of inflammation can foresee an individual risk of developing heart and vascular diseases or early death 40 years before real problems arise. The authors of the development are the scientists of Sloan Kettering Cancer Center.
Scientists have found that Wolbachia bacterium used to fight mosquitoes can be a very cheap and effective way to fight dengue virus.
A group of scientists from NUST MISiS, has created a new material for medical implants that simplifies recovery from fractures, Remedium reports. The secret is to use platinum and iron nanoparticles. They allow to destroy up to 98% of harmful bacteria, as a result to reduce the risk of postoperative infections.
Kadimastem Company from Israeli has reported that the rodent trials of the new IsletRx anti-diabetes drug have been successfully completed. As Xinhua notes, therapy is based on working pancreatic cells and a unique microencapsulation technology. The experiments have proved the safety of the delivery method and the effectiveness of therapy (blood sugar levels were within the normal range).
The University of Northern Carolina has established that mainly cancer develops as a result of the interaction of bacteria and glycoprotein MUC1, which covers the surface of epithelial cells in the body. According to Eurolab, MUC1 is present in almost all glandular epithelial cells.
Oramed Pharmaceuticals Company from Israeli has reported the successful test of insulin capsules helping to control diabetes. As Xinhua notes, a drug known as ORMD-0801 may become the first oral form of insulin.
American researchers are working on a universal flu vaccine that should work against both seasonal and pandemic influenza. Clinical examination results were very encouraging - the vaccine showed efficacy.
As Xinhua notes, a group of Canadian doctors performed the world's first brain aneurysm surgery by using a robotic system. According to the doctors, the use of robotic technologies may improve the quality of treatment for patients with aneurysm and stroke.
Zio patch applied to the chest can prevent stroke and heart attack by detecting an abnormal heartbeat. It is hard to identify the changes in heart rhythm that occur infrequently (1-2 times a week). According to The Daily Mail, Zio patch is approximately 8 times more effective than standard sensors that monitor the heartbeat.
In March next year, a unique product is going to be launched on the market in the United States - the first contact lenses named MiSight and manufactured by CooperVision are intended to slow down the development of myopia in children aged 8-12 years, Remedium reports..